About me

Neurologist trained at Hospital Clínic de Barcelona (2000) and PhD in Biopathology from the University of Barcelona (2003). Following a Rio Hortega contract (ISCIII) for a specialisation in cognitive neurology, which included a short postdoctoral stay at UCSF, I was appointed as a neurologist at Hospital Clínic Barcelona (2006). Since 2018, I have led the Alzheimer’s Group at FRCB-IDIBAPS. I held the position of Associate professor at the University of Barcelona. From 2018 to 2023, I served as Head of Neurology, and beginning in January 2024, I assumed the role of Medical Director at Clínic Barcelona.

Featured publications

Featured Projects

  • Genetic dementias (genetic Alzheimer’s disease, frontotemporal dementia and prion diseases):longitudinal changes and expression and epigenetic differences with sporadic cases.

    Principal investigator: Raquel Sanchez del Valle Díaz
    Funder: Instituto de Salud Carlos III
    Code: PI20/ 00448
    Duration: 01/01/2021 - 30/06/2025
  • Estudio de biomarcadores y desarrollo de nuevas estrategias terapéuticas en una cohorte multicéntrica de Demencia Frontotemporal.

    Principal investigator: Raquel Sanchez del Valle Díaz
    Funder: Departament de Salut de la Generalitat de Catalunya
    Code: SLT002/16/00408
    Duration: 27/03/2017 - 31/12/2023
  • Study of genetic frontotemporal dementia in preclinical and early stages of the disease: cognitive performance, structural and functional neuroimaging and biochemical markers.

    Principal investigator: Raquel Sanchez del Valle Díaz
    Funder: Fundació La Marató de TV3
    Code: TV3-20143810
    Duration: 15/05/2015 - 15/11/2021
  • Phase II/III Randomized, Double-Blind, Placebo-Controlled Multi-Center Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease

    Principal investigator: Raquel Sanchez del Valle Díaz
    Funder: National Institute on Aging (NIH)
    Duration: 14/07/2014
  • Alzheimer’s Disease Prediction Service (ADPS): digital biomarker for Real-World Evidence (RWE) in AD

    Principal investigator: Raquel Sanchez del Valle Díaz
    Funder: EIT Health
    Code: EIT Health 18066/2017
    Duration: 01/01/2018 - 31/12/2018